If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

Share Price is delayed by 15 minutes
Get Live Data
14,665.00    -30.00 (-0.20%)
Bid:
14,660.00
Ask:
14,670.00
Spread: 10.00 (0.068%)
Market Cap: £16.74b
NXT Live PriceLast checked at - London Stock Exchange

Intraday Next Share Chart

AGM Update

13 Nov 2023 12:30

RNS Number : 2647T
Next PLC
13 November 2023
 

13 November 2023

 

NEXT plc ("the Company" or "NEXT")

 

AGM Update

All resolutions put to shareholders at the NEXT 2023 Annual General Meeting ("the AGM") on 18 May 2023 were passed. A minority (20.84%) of shareholders that voted, chose not to support resolution 12 which related to the re-election of the Company's Non-Executive Chair, Mr. Michael Roney, as a director of the Company.

 

In line with the provisions of the 2018 UK Corporate Governance Code, the Company engaged in a consultation process with shareholders to gain an understanding of their reasons for voting against the re-election of Mr. Roney and now provides this update on the views received from shareholders.

 

Based on the views expressed by those shareholders before the AGM and who were identified as having voted against and who responded to the consultation, the level of votes against Mr. Roney's re-election were primarily due to him being considered as overboarded with a secondary concern relating to the gender make up of the Board.

 

The Board accepts that some investors apply a stricter voting policy than the market generally in relation to Chair and Directorship roles on the boards of listed companies. Mr. Roney provides more than enough time to his role as Chair and effectively discharges the functions and obligations of the role. He has attended all Board and Committee meetings held in the past three years. He is always available when required as was evident in the Group's response to the pandemic and his involvement in the major strategic decisions made by the Board in recent years.

 

The NEXT Nomination Committee monitors Directors' external commitments and would take appropriate action in the event of any concerns being raised about the ability of any director, including the Chair, to dedicate sufficient time to their roles.

 

Mr. Roney brings significant experience to his role at NEXT, provides clear direction and leadership to the Board and the Board believes that his continuing appointment as Chair is for the benefit of all stakeholders in the Company.

 

The Company will set out further details on these matters in the 2024 Annual Report.

 

 

Ian Blackwell

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMGPGWPGUPWGPW
Date   Source Headline
27th Sep 20245:15 pmRNSTransaction in Own Shares
27th Sep 202412:01 pmRNSDirector/PDMR Shareholding
23rd Sep 20245:19 pmRNSTransaction in Own Shares
20th Sep 20245:08 pmRNSTransaction in Own Shares
20th Sep 20244:31 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSResults for the Half Year Ended July 2024
9th Sep 20244:58 pmRNSTransaction in Own Shares
6th Sep 20245:00 pmRNSTransaction in Own Shares
5th Sep 20245:19 pmRNSTransaction in Own Shares
4th Sep 20245:12 pmRNSTransaction in Own Shares
3rd Sep 20244:57 pmRNSTransaction in Own Shares
2nd Sep 20244:52 pmRNSHolding(s) in Company
2nd Sep 20248:46 amRNSTotal Voting Rights
22nd Aug 20245:15 pmRNSTransaction in Own Shares
21st Aug 20245:00 pmRNSTransaction in Own Shares
20th Aug 20245:00 pmRNSTransaction in Own Shares
19th Aug 20245:16 pmRNSTransaction in Own Shares
16th Aug 20245:09 pmRNSTransaction in Own Shares
15th Aug 20245:15 pmRNSTransaction in Own Shares
14th Aug 20245:14 pmRNSTransaction in Own Shares
13th Aug 20245:02 pmRNSTransaction in Own Shares
12th Aug 20245:03 pmRNSTransaction in Own Shares
9th Aug 20245:14 pmRNSTransaction in Own Shares
8th Aug 20245:17 pmRNSTransaction in Own Shares
7th Aug 20244:54 pmRNSTransaction in Own Shares
6th Aug 20245:07 pmRNSTransaction in Own Shares
5th Aug 20245:02 pmRNSTransaction in Own Shares
2nd Aug 20244:54 pmRNSTransaction in Own Shares
1st Aug 20245:09 pmRNSTransaction in Own Shares
1st Aug 20249:00 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSTrading Statement
31st Jul 20245:03 pmRNSTransaction in Own Shares
30th Jul 20245:11 pmRNSTransaction in Own Shares
29th Jul 20245:07 pmRNSTransaction in Own Shares
26th Jul 20245:14 pmRNSTransaction in Own Shares
26th Jul 20244:22 pmRNSSection 430 (2B) Companies Act 2006 Statement
25th Jul 20244:57 pmRNSTransaction in Own Shares
24th Jul 20244:55 pmRNSTransaction in Own Shares
23rd Jul 20245:31 pmRNSTransaction in Own Shares
22nd Jul 20245:11 pmRNSTransaction in Own Shares
19th Jul 20245:05 pmRNSTransaction in Own Shares
18th Jul 20244:56 pmRNSTransaction in Own Shares
17th Jul 20245:10 pmRNSTransaction in Own Shares
16th Jul 20245:18 pmRNSTransaction in Own Shares
15th Jul 20245:24 pmRNSTransaction in Own Shares
12th Jul 20245:01 pmRNSTransaction in Own Shares
11th Jul 20246:16 pmRNSTransaction in Own Shares
10th Jul 20244:51 pmRNSTransaction in Own Shares
9th Jul 20244:58 pmRNSTransaction in Own Shares
8th Jul 20245:36 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.